212 related articles for article (PubMed ID: 18400335)
1. A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.
Du H; Wang J; Zhang X; Hu Z
Eur J Med Chem; 2008 Dec; 43(12):2861-9. PubMed ID: 18400335
[TBL] [Abstract][Full Text] [Related]
2. New ligands at the melatonin binding site MT(3).
Boussard MF; Truche S; Rousseau-Rojas A; Briss S; Descamps S; Droual M; Wierzbicki M; Ferry G; Audinot V; Delagrange P; Boutin JA
Eur J Med Chem; 2006 Mar; 41(3):306-20. PubMed ID: 16414149
[TBL] [Abstract][Full Text] [Related]
3. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.
Tan DX; Manchester LC; Terron MP; Flores LJ; Tamura H; Reiter RJ
J Pineal Res; 2007 Nov; 43(4):317-20. PubMed ID: 17910598
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
[TBL] [Abstract][Full Text] [Related]
5. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate.
Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G
J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489
[TBL] [Abstract][Full Text] [Related]
6. Prediction of fungicidal activities of rice blast disease based on least-squares support vector machines and project pursuit regression.
Du H; Wang J; Hu Z; Yao X; Zhang X
J Agric Food Chem; 2008 Nov; 56(22):10785-92. PubMed ID: 18950187
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme.
Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA
Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234
[TBL] [Abstract][Full Text] [Related]
8. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3.
Mailliet F; Ferry G; Vella F; Thiam K; Delagrange P; Boutin JA
FEBS Lett; 2004 Dec; 578(1-2):116-20. PubMed ID: 15581627
[TBL] [Abstract][Full Text] [Related]
9. Prediction of binding affinities to beta1 isoform of human thyroid hormone receptor by genetic algorithm and projection pursuit regression.
Ren Y; Liu H; Li S; Yao X; Liu M
Bioorg Med Chem Lett; 2007 May; 17(9):2474-82. PubMed ID: 17337187
[TBL] [Abstract][Full Text] [Related]
10. [New naphthalenic ligands of melatoninergic receptors].
Adam G; Guardiola-Lemaitre B; Yous S; Lesieur D; Morgan P; Howell HE; Andrieux J; Caignard DH; Pfeiffer B; Renard P
J Pharm Belg; 1992; 47(4):374-80. PubMed ID: 1328595
[TBL] [Abstract][Full Text] [Related]
11. Application of genetic algorithm-support vector machine (GA-SVM) for prediction of BK-channels activity.
Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
Eur J Med Chem; 2009 Dec; 44(12):5023-8. PubMed ID: 19837488
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Ettaoussi M; Péres B; Klupsch F; Delagrange P; Boutin JA; Renard P; Caignard DH; Chavatte P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 May; 16(9):4954-62. PubMed ID: 18372181
[TBL] [Abstract][Full Text] [Related]
13. Quinone reductase 2 and antidepressant effect of melatonin derivatives.
Oxenkrug GF; Bachurin SO; Prakhie IV; Zefirov NS
Ann N Y Acad Sci; 2010 Jun; 1199():121-4. PubMed ID: 20633117
[TBL] [Abstract][Full Text] [Related]
14. Prediction of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.
Yuan Y; Zhang R; Hu R; Ruan X
Eur J Med Chem; 2009 Jan; 44(1):25-34. PubMed ID: 18433938
[TBL] [Abstract][Full Text] [Related]
15. QSAR study on melanocortin-4 receptors by support vector machine.
Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
Eur J Med Chem; 2010 Mar; 45(3):1087-93. PubMed ID: 20031282
[TBL] [Abstract][Full Text] [Related]
16. A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine.
Fatemi MH; Gharaghani S
Bioorg Med Chem; 2007 Dec; 15(24):7746-54. PubMed ID: 17870538
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of melatonin ligands.
Delagrange P; Boutin JA
Chronobiol Int; 2006; 23(1-2):413-8. PubMed ID: 16687314
[TBL] [Abstract][Full Text] [Related]
18. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
Mor M; Rivara S; Lodola A; Lorenzi S; Bordi F; Plazzi PV; Spadoni G; Bedini A; Duranti A; Tontini A; Tarzia G
Chem Biodivers; 2005 Nov; 2(11):1438-51. PubMed ID: 17191945
[TBL] [Abstract][Full Text] [Related]
19. Simultaneously optimized support vector regression combined with genetic algorithm for QSAR analysis of KDR/VEGFR-2 inhibitors.
Sun M; Chen J; Cai J; Cao M; Yin S; Ji M
Chem Biol Drug Des; 2010 May; 75(5):494-505. PubMed ID: 20486936
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
